Literature DB >> 17298728

Hydrosalpinx and IVF: assessment of treatments implemented prior to IVF.

B Ozmen1, K Diedrich, S Al-Hasani.   

Abstract

It is well known that the success of artificial reproductive techniques, especially IVF, for patients with tubal pathologies such as hydrosalpinx is reduced by half compared with patients without hydrosalpinx. Notably, there are also substantial increases in both early pregnancy loss and ectopic pregnancies. Alterations in the outcome of these patients generally reflect a detrimental effect of hydrosalpinx. However, although many theories have been published, a single explanation has not yet been found over a period of decades. Therefore, the negative effects of hydrosalpinx have generally been attributed largely to: (i) mechanical effects; (ii) embryo and gametotoxicity; (iii) alterations in endometrial receptivity markers; or dwindled cross talk between embryo-endometrium resulting in hindered implantation, and (iv) direct effect on endometrium, leading to intrauterine fluid formation. On the other hand, the most important question is selection of the preferred treatment option with either surgical or medical therapies. How should hydrosalpinx be managed? Does selection of the surgical method, either proximal obstruction or salpingectomy, depending on patients' clinical findings, differ in outcome, or is routine prophylactic salpingectomy needed? Additionally, the requirement for IVF or intracytoplasmic sperm injection is still controversial in patients with unilateral hydrosalpinx who have been treated with unilateral salpingectomy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17298728     DOI: 10.1016/s1472-6483(10)60792-4

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  8 in total

1.  Ectopic pregnancy after infertility treatment.

Authors:  Madhuri Patil
Journal:  J Hum Reprod Sci       Date:  2012-05

2.  Hydrosalpinx functional surgery or salpingectomy? The importance of hydrosalpinx fluid in assisted reproductive technologies.

Authors:  Mandakini Parihar; Aparna Mirge; Reshma Hasabe
Journal:  J Gynecol Endosc Surg       Date:  2009-01

3.  Cell-type specific analysis of physiological action of estrogen in mouse oviducts.

Authors:  Emily A McGlade; Gerardo G Herrera; Kalli K Stephens; Sierra L W Olsen; Sarayut Winuthayanon; Joie Guner; Sylvia C Hewitt; Kenneth S Korach; Francesco J DeMayo; John P Lydon; Diana Monsivais; Wipawee Winuthayanon
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.834

4.  Oviductal estrogen receptor α signaling prevents protease-mediated embryo death.

Authors:  Wipawee Winuthayanon; Miranda L Bernhardt; Elizabeth Padilla-Banks; Page H Myers; Matthew L Edin; Fred B Lih; Sylvia C Hewitt; Kenneth S Korach; Carmen J Williams
Journal:  Elife       Date:  2015-12-01       Impact factor: 8.140

5.  A comprehensive analysis of miRNA/isomiRs profile of hydrosalpinx patients with interventional ultrasound sclerotherapy.

Authors:  Zhengyi Cao; Bo Xu; Yan Wu; Kang Luan; Xin Du
Journal:  PLoS One       Date:  2022-08-15       Impact factor: 3.752

6.  Endometrial appearance in the presence of communicating hydrosalpinx.

Authors:  Rj Heitmann; Ro Burney
Journal:  J Surg Case Rep       Date:  2012-01-01

7.  Clinical application of operative hysteroscopy in treatment of complex hydrosalpinx prior to IVF.

Authors:  Hong-Chu Bao; Mei-Mei Wang; Xin-Rong Wang; Wen-Juan Wang; Cui-Fang Hao
Journal:  Iran J Reprod Med       Date:  2015-05

8.  Two-year outcome after recurrent implantation failure: prognostic factors and additional interventions.

Authors:  Christiane Kling; Andreas Schmutzler; Georg Wilke; Jürgen Hedderich; Dieter Kabelitz
Journal:  Arch Gynecol Obstet       Date:  2008-01-12       Impact factor: 2.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.